Richard John Rees Purchases 4,712 Shares of Creo Medical Group PLC (LON:CREO) Stock

Creo Medical Group PLC (LON:CREO - Get Free Report) insider Richard John Rees purchased 4,712 shares of the company's stock in a transaction dated Thursday, January 16th. The shares were bought at an average cost of GBX 19 ($0.23) per share, for a total transaction of £895.28 ($1,103.92).

Richard John Rees also recently made the following trade(s):

• On Thursday, October 24th, Richard John Rees acquired 98,000 shares of Creo Medical Group stock. The stock was acquired at an average cost of GBX 20 ($0.25) per share, for a total transaction of £19,600 ($24,167.69).

Creo Medical Group Price Performance

LON:CREO remained flat at GBX 18.50 ($0.23) during trading hours on Tuesday. 222,732 shares of the company's stock traded hands, compared to its average volume of 735,321. The stock has a market capitalization of £66.93 million, a P/E ratio of -308.33 and a beta of 0.86. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96. Creo Medical Group PLC has a twelve month low of GBX 12 ($0.15) and a twelve month high of GBX 43 ($0.53). The firm has a 50-day moving average of GBX 17.54 and a 200 day moving average of GBX 23.61.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.